Assessment of the PEEP Responsiveness to Titrate End-expiratory Pressure and of the Need for Muscle Relaxation During Prone Positioning in Moderate-to-severe Acute Respiratory Distress Syndrome: A Master Protocol

Trial statusRecruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age18+
SponsorAssistance Publique - Hôpitaux de Paris

About this trial

Despite best supportive care, mortality of the Acute Respiratory Distress Syndrom (ARDS) remains high. In the absence of specific treatments, providing safe and efficient mechanical ventilation (MV) is key to survival.

The use of low tidal volumes (VT) and plateau pressures (PPLAT) improves survival in randomized controlled trials (RCTs), but the safest VT to be applied for each patient remains unknown. Whether targeting low ∆P instead of a 6 mL/kg VT improves outcome has not been tested prospectively. The optimal method to set PEEP is also a matter of debate. As the amount of potentially recruitable lung vary widely among patients and is strongly associated with the response to PEEP, it may be necessary to tailor PEEP settings based on the response to a PEEP trial.

The first aim is to test a personalized approach to set PEEP widely supported by the literature. The first hypothesis is that i) patients with greater amounts of recruitable lung may benefit from higher PEEP levels, provided that attention is paid to maintain ∆P below 14 cmH2O, ii) setting PEEP based on results of a PEEP-responsiveness test improves survival as compared to low- and high-PEEP strategies applied independently of the patient response.

Apart from VT reduction and PPLAT control below 30 cmH2O, only 2 interventions demonstrated a reduction of mortality in large RCTs: a 48-hour continuous infusion of neuromuscular blocking agents (NMBAs) at the acute phase of ARDS6 and the use of prone positioning (PP). Whereas there is little doubt on the utility of PP in patients with PaO2/FiO2 ratio \< 150 mmHg, there is more controversy on the impact of NMBAs on survival. Despite a strong rationale and a very widespread use in clinical practice, no current guidelines answer the question of the best timing of muscle relaxation in moderate to severe ARDS patients treated with PP.

As a second aim, the hypothesis is that the early systematic and combined use of NMBAs improved survival of patients with moderate to severe ARDS requiring prone positioning after optimization of PEEP settings.

Eligibility criteria

This trial does not accept healthy volunteers

Qualifiers

Invasive mechanical ventilation within 96 hours of ICU admission and within 72 hours of tracheal intubation for first randomization and then within 72 hours of the first randomization for the second randomization

Patients meeting the Berlin ARDS definition criteria with hypoxemia characterized as

for first randomization: PaO2/FiO2 ≤150 mmHg on a PEEP ≥5 cmH2O with FiO2≥0.6 while VT is 6 ml/kg Predicted Body Weight (PBW) and adequate sedation level to adjust mechanical ventilation settings

for second randomization: PaO2/FiO2 ≤150 mmHg on optimized ventilatory settings according to the first randomization, confirmed by two Arterial blood gas (ABG) analyses separated by an interval time of 4 hours and observed within 72 hours of the first randomization

Disqualifiers

Age < 18 years

Known pregnancy or breastfeeding

Participation in another interventional studies as long as these studies do not interfere with the primary endpoint and the secondary safety objectives of PEPER, or being in the exclusion period at the end of a previous study.

Intracranial pressure > 30 mm Hg or cerebral perfusion pressure < 60 mmHg

Trial design

Design model

Parallel

Treatments tested in this trial

  • Minimal distension

    Other intervention

    Patients receive tidal volume (VT) of 6 mL/kg and conservative positive end-expiratory pressure (PEEP) setting.

  • Maximal Recruitment

    Other intervention

    Patients receive tidal volume adjusted to limit plateau pressure (∆P) to 14 cmH2O and the highest possible PEEP while maintaining plateau pressure (PPLAT) ≤ 27 cmH2O.

  • Prone position + early NMBAs

    Other intervention

    NMBAs given as soon as possible after randomization

  • Prone position + rescue NMBAs

    Other intervention

    NMBAs given only as a rescue

Treatment groups

1,200 Participants
are divided into 5 treatment groups
Group A: First randomization : Arm A : Routine care Minimal distentionActive comparator 1 intervention
Group B: First randomization : Arm B Routine care maximal recruitmentActive comparator 1 intervention
Group C: First randomization: Arm C : Decision of th ventilation strategy according to the PRT resultExperimental treatment 2 interventions
Group D: Second randomization : NMBAs used as a rescueActive comparator 1 intervention
Group E: Second randomization : early NMBAs used as soon as possibleExperimental treatment 1 intervention

Trial outcomes

Primary outcomes

1

28-day all-cause mortality

Time frame
28 days after randomization

Secondary outcomes

1

Ratio of arterial oxygen partial pressure to inspired oxygen fraction

PaO2/FiO2

Time frame
24 hours after randomization
2

Ratio of arterial oxygen partial pressure to inspired oxygen fraction

PaO2/FiO2

Time frame
48 hours after randomization
3

Ratio of arterial oxygen partial pressure to inspired oxygen fraction

PaO2/FiO2

Time frame
72 hours after randomization
4

Ratio of arterial oxygen partial pressure to inspired oxygen fraction

PaO2/FiO2

Time frame
7 days after randomization

Other outcomes

1

Death with refractory hypoxemia

Defined as PaO2/FiO2\< 80 mmHg outside a care incident

Time frame
Up to day 7
2

Death with refractory acidosis

Defined as Ph\<7.10 despite Respiratory Rate (RR) ≥ 35 /min \& VT 8 ml/kg

Time frame
Up to day 7
3

Death with barotrauma

Time frame
Up to day 7
4

Need of commencement or 30% increase in vasopressors or hypotension (MAP<60 mmHg)

Time frame
Within 8 hours after randomization

Sponsors and contacts

Click on the lead sponsor to view all of their trials.